Long-term effect of intravitreal injection of anti-VEGF agent for visual acuity and chorioretinal atrophy progression in myopic choroidal neovascularization (Q83970853)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 April 2012

Language	Label	Description	Also known as
English	Long-term effect of intravitreal injection of anti-VEGF agent for visual acuity and chorioretinal atrophy progression in myopic choroidal neovascularization	scientific article published on 19 April 2012

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527326%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Long-term effect of intravitreal injection of anti-VEGF agent for visual acuity and chorioretinal atrophy progression in myopic choroidal neovascularization (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527326%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527326%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Masahiro Miyake

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527326%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

object named as

Hiroshi Tamura

5

1 reference

ORCID Public Data File 2021

author name string

Kenji Yamashiro

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527326%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Akitaka Tsujikawa

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527326%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sotaro Ooto

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527326%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Isao Nakata

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527326%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Nagahisa Yoshimura

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527326%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

19 April 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527326%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Graefe's Archive for Clinical and Experimental Ophthalmology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527326%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

251

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527326%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527326%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1-7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527326%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

https://scigraph.springernature.com/pub.10.1007/s00417-012-2022-8

0 references

Two-year comparison of photodynamic therapy and intravitreal bevacizumab for treatment of myopic choroidal neovascularisation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathologic Myopia and Choroidal Neovascularization

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in refraction over 10 years in an adult population: the Beaver Dam Eye study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bevacizumab for choroidal neovascularization secondary to pathologic myopia: Is there a decline of the treatment efficacy after 2 years?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ranibizumab Treatment for Choroidal Neovascularization from Causes Other than Age-Related Macular Degeneration and Pathological Myopia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Photodynamic therapy to treat choroidal neovascularisation in highly myopic patients: 4 years' outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal ranibizumab as primary treatment for neovascular membrane associated with idiopathic juxtafoveal retinal telangiectasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Twelve-month outcome after one intravitreal injection of bevacizumab to treat myopic choroidal neovascularization.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myopic choroidal neovascularization: a 10-year follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sterile endophthalmitis after intravitreal injection of bevacizumab obtained from a single batch

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal ranibizumab for myopic choroidal neovascularization: 12-month results.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visual acuity outcomes of patients 50 years of age and older with high myopia and untreated choroidal neovascularization

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: one-year results.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is ranibizumab effective in stopping the loss of vision for choroidal neovascularisation in pathologic myopia? A long-term follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab to treat myopic choroidal neovascularization: 2-year outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Choroidal neovascularization in pathologic myopia: recent developments in diagnosis and treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal ranibizumab for choroidal neovascularization complicating pathologic myopia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characteristics of patients with a favorable natural course of myopic choroidal neovascularization

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: visual outcome in relation to age at treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: 12-month results.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab versus photodynamic therapy for myopic choroidal neovascularization in a North-African population.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pathogenesis of congenital myopia. A study of 66 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-Term Follow-Up of Myopic Choroidal Neovascularization Treated with Ranibizumab

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors associated with the development of chorioretinal atrophy around choroidal neovascularization in pathologic myopia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal ranibizumab for the primary treatment of choroidal neovascularization secondary to pathologic myopia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myopic choroidal neovascularization: natural course and treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of visual outcome and regression pattern of myopic choroidal neovascularization after intravitreal bevacizumab or after photodynamic therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term results of photodynamic therapy for choroidal neovascularization in Japanese patients with pathologic myopia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age-related decreases in the prevalence of myopia: longitudinal change or cohort effect?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal ranibizumab for myopic choroidal neovascularization: factors predictive of visual outcome and need for retreatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab treatment for choroidal neovascularization in pathologic myopia: 12-month results

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two-year outcomes of intravitreal bevacizumab for choroidal neovascularization in Japanese patients with pathologic myopia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Choroidal neovascularisation in pathological myopia: an update in management

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors for visual outcomes 2-years after intravitreal bevacizumab for myopic choroidal neovascularization

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subretinal fibrosis after photodynamic therapy in subfoveal choroidal neovascularisation in highly myopic eyes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two-year visual results for older Asian women treated with photodynamic therapy or bevacizumab for myopic choroidal neovascularization.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal injection of 2.5 mg bevacizumab for treatment of myopic choroidal neovascularization in treatment-naive cases: a 2-year follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83970853&oldid=1754772469"